Re: Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review
(Source: BMJ Comments)
Source: BMJ Comments - October 14, 2018 Category: General Medicine Source Type: forums
Re: Diclofenac use and cardiovascular risks: series of nationwide cohort studies
(Source: BMJ Comments)
Source: BMJ Comments - October 9, 2018 Category: General Medicine Source Type: forums
Re: Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study
(Source: BMJ Comments)
Source: BMJ Comments - September 17, 2018 Category: General Medicine Source Type: forums
Re: Diclofenac use and cardiovascular risks: series of nationwide cohort studies
(Source: BMJ Comments)
Source: BMJ Comments - September 11, 2018 Category: General Medicine Source Type: forums
Re: Environmental metals and cardiovascular disease
(Source: BMJ Comments)
Source: BMJ Comments - August 31, 2018 Category: General Medicine Source Type: forums
Risk of adverse cardiovascular outcomes in patients with diabetes who fast whilst taking sulphonylureas
(Source: BMJ Comments)
Source: BMJ Comments - August 23, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - July 25, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study - Lesson learned is using the two-edged sword judiciously
(Source: BMJ Comments)
Source: BMJ Comments - July 22, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - July 22, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study - Lesson learned is using the two-edged sword judiciously
(Source: BMJ Comments)
Source: BMJ Comments - July 22, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - July 20, 2018 Category: General Medicine Source Type: forums
